Perputaran Kas Persediaan Likuiditas Leverage dan Profitabilitas PT Indofarma Tbk Studi Eksploratif Kuartalan 2023–2025

Authors

  • Vika Liviana Universitas Sains Al-Qur'an
  • Lia Dewi Munfarida Universitas Sains Al-Qur'an
  • Isma Melati Universitas Sains Al-Qur'an
  • Niken Kusdayanti Universitas Sains Al-Qur’an

DOI:

https://doi.org/10.51903/586wqh12

Keywords:

cash turnover, inventory turnover, leverage, liquidity, profitability

Abstract

This study explores the associations of cash turnover, inventory turnover, liquidity, and leverage with the profitability of PT Indofarma Tbk over 2023–2025. Eleven reporting-date observations were reconstructed from financial statements; the first quarter of 2024 was excluded because all required accounts could not be verified. Profitability is measured by return on assets, liquidity by the current ratio, and leverage by the liabilities-to-assets ratio. The nine-month 2023 cost of goods sold was corrected to IDR435.464 billion. Ordinary least squares, HC3 covariance estimation, and sensitivity analyses were applied to cumulative year-to-date ratios. The conventional model yielded R² = 0.8095 and an inventory-turnover coefficient of −18.723 (p = 0.004). However, this coefficient was not significant with HC3 inference (p = 0.193), and joint significance disappeared (p = 0.646). Serious collinearity between liquidity and leverage, influential observations, and the change from consolidated reporting to parent-only statements in 2025 limit interpretation. The results describe fragile sample associations and do not establish causal effects. Inventory valuation and reporting comparability should be examined before interpreting turnover ratios as operational efficiency.

References

S. A. Ross, R. W. Westerfield, J. Jaffe, and B. D. Jordan, Corporate finance, 13th ed. McGraw-Hill Education, 2022.

M. D. Ayoush, A. A. Toumeh, and K. I. Shabaneh, “Liquidity, leverage, and solvency: What affects profitability of industrial enterprises the most?,” Investment Management and Financial Innovations, vol. 18, no. 3, pp. 249–259, 2021, doi: 10.21511/imfi.18(3).2021.22.

T. N. L. Nguyen and V. C. Nguyen, “The determinants of profitability in listed enterprises: A study from Vietnamese stock exchange,” Journal of Asian Finance, Economics and Business, vol. 7, no. 1, pp. 47–58, 2020.

S. L. Nguyen, C. D. Pham, T. V. Truong, T. V. Phi, L. T. Le, and T. T. T. Vu, “Relationship between capital structure and firm profitability: Evidence from Vietnamese listed companies,” International Journal of Financial Studies, vol. 11, no. 1, 2023, Art. no. 45, doi: 10.3390/ijfs11010045.

M. Yousaf, P. Briš, and I. Haider, “Working capital management and firm’s profitability: Evidence from Czech certified firms from the EFQM excellence model,” Cogent Economics & Finance, vol. 9, no. 1, 2021, Art. no. 1954318, doi: 10.1080/23322039.2021.1954318.

N. Assaf, “The impact of working capital management on firm profitability of non-financial companies listed on Palestine Security Exchange,” Palestine Technical University Research Journal, vol. 10, no. 1, pp. 1–10, 2022.

A. Habib, M. A. Khan, J. Popp, and M. Harangi-Rákos, “The influence of operating capital and cash holding on firm profitability,” Economies, vol. 10, no. 3, 2022, Art. no. 69, doi: 10.3390/economies10030069.

A. H. Nguyen, H. T. Pham, and H. T. Nguyen, “Impact of working capital management on firm’s profitability: Empirical evidence from Vietnam,” Journal of Asian Finance, Economics and Business, vol. 7, no. 3, pp. 115–125, 2020.

F. Walyya, D. Muchtar, and I. Bensaadi, “Perputaran persediaan, perputaran piutang, likuiditas dan profitabilitas: Analisis peran leverage pada perusahaan farmasi di Bursa Efek Indonesia,” Jurnal Bisnis, Manajemen dan Teknososiopreneur, vol. 1, no. 1, pp. 40–49, 2022, doi: 10.31326/bimtek.v1i1.1254.

D. Hertina, V. S. A. Lase, and I. Syahril, “Profitabilitas dampak dari likuiditas, leverage dan aktivitas,” Fair Value: Jurnal Ilmiah Akuntansi dan Keuangan, vol. 4, no. 9, pp. 3863–3868, 2022.

H. Kiymaz, S. Haque, and A. A. Choudhury, “Working capital management and firm performance: A comparative analysis of developed and emerging economies,” Borsa Istanbul Review, vol. 24, no. 3, pp. 634–642, 2024, doi: 10.1016/j.bir.2024.03.004.

S. Zhou, B. A. Amin Noordin, M. B. Tunde, Y. Chen, and K. Xu, “Working capital management and corporate profitability: The moderating role of foreign ownership,” Finance Research Letters, vol. 81, 2025, Art. no. 107466, doi: 10.1016/j.frl.2025.107466.

Badan Pemeriksa Keuangan Republik Indonesia, Ikhtisar hasil pemeriksaan semester II tahun 2023. BPK RI, 2024.

Bisnis.com, “Modus fraud Indofarma: Transaksi fiktif, pinjol, hingga windows dressing,” Jun. 4, 2024. [Online]. Available: https://market.bisnis.com/read/20240604/192/1771070/modus-fraud-indofarma-transaksi-fiktif-pinjol-hingga-windows-dressing

Detik Finance, “Temuan BPK: Indofarma terjerat pinjol!,” Jun. 6, 2024. [Online]. Available: https://finance.detik.com/berita-ekonomi-bisnis/d-7377599/temuan-bpk-indofarma-terjerat-pinjol

H. M. D. Nugraha and R. A. Rahadi, “Financial performance analysis and Z-score assessment of pharmaceutical industry during and after economic crisis in 2020,” Al-Kharaj: Jurnal Ekonomi, Keuangan & Bisnis Syariah, vol. 7, no. 3, 2025.

V. Agrawal, “Financial flexibility, working capital efficiency and profitability in the Indian pharmaceutical sector: Evidence from panel data (2016–2025),” International Journal of Pharmaceutical and Healthcare Marketing, early access, 2026, doi: 10.1108/ijphm-07-2025-0163.

F. Silva and S. Silva, “Working capital management and corporate performance: The role of financial constraints,” International Review of Economics & Finance, vol. 106, 2026, Art. no. 104926, doi: 10.1016/j.iref.2026.104926.

A. Kukeli, B. Widner, F. Deari, G. Sargsyan, and N. Barbuta-Misu, “Firm profitability and economic crises: The non-linear role of the cash conversion cycle,” International Journal of Financial Studies, vol. 13, no. 2, 2025, Art. no. 86, doi: 10.3390/ijfs13020086.

I. Kalash, “How does excess cash affect corporate financial performance?,” Journal of Applied Accounting Research, vol. 25, no. 5, pp. 1223–1243, 2024, doi: 10.1108/jaar-08-2023-0231.

J. M. B. Butar and S. Saryadi, “Pengaruh perputaran kas, perputaran piutang, dan perputaran persediaan terhadap profitabilitas (Studi pada perusahaan sub sektor farmasi di Bursa Efek Indonesia periode 2014–2019),” Jurnal Ilmu Administrasi Bisnis, vol. 9, no. 4, pp. 420–430, 2020.

R. W. Wanzala and L. Obokoh, “The effects of working capital management on the financial performance of commercial and service firms listed on the Nairobi Securities Exchange in Kenya,” Risks, vol. 12, no. 8, 2024, Art. no. 119, doi: 10.3390/risks12080119.

T. X. T. Huynh, T. T. H. Nguyen, and C. V. Nguyen, “The impact of working capital management on the financial performance of listed enterprises: An empirical evidence from Vietnam,” Cogent Business & Management, vol. 12, no. 1, 2025, Art. no. 2473033, doi: 10.1080/23311975.2025.2473033.

P. Ratajczak, D. Szutowski, and J. Nowicki, “Exploring the dynamics of profitability–liquidity relations in crisis, pre-crisis and post-crisis,” International Journal of Financial Studies, vol. 12, no. 1, 2024, Art. no. 16, doi: 10.3390/ijfs12010016.

L. Cathcart, A. Dufour, L. Rossi, and S. Varotto, “Corporate bankruptcy and banking deregulation: The effect of financial leverage,” Journal of Banking & Finance, vol. 166, 2024, Art. no. 107219, doi: 10.1016/j.jbankfin.2024.107219.

J. M. Wooldridge, Introductory econometrics: A modern approach, 7th ed. Cengage Learning, 2020.

PT Indofarma Tbk, Laporan keuangan konsolidasian tidak diaudit 31 Maret 2023 dan untuk periode tiga bulan yang berakhir pada tanggal tersebut, 2023. [Online]. Tersedia: https://indopremier.com/xdir/news/LAPORAN%20KEUANGAN/q1_2023/INAF_Q1_2023.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian tidak diaudit 30 Juni 2023 dan untuk periode enam bulan yang berakhir pada tanggal tersebut, 2023. [Online]. Tersedia: https://www.indopremier.com/xdir/news/LAPORAN%20KEUANGAN/q2_2023/INAF_Q2_2023.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian tidak diaudit 30 September 2023 dan untuk periode sembilan bulan yang berakhir pada tanggal tersebut, 2023. [Online]. Tersedia: https://www.idx.co.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202310/c6e4504746_285f04103c.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian 31 Desember 2023 dan untuk tahun yang berakhir pada tanggal tersebut, 2024. [Online]. Tersedia: https://indopremier.com/xdir/news/LAPORAN%20KEUANGAN/q4_2023/INAF_Q4_2023.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian 30 Juni 2024 dan untuk periode enam bulan yang berakhir pada tanggal tersebut, 2024. [Online]. Tersedia: https://www.indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2024/q2/INAF_Q2_2024.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian 30 September 2024 dan untuk periode sembilan bulan yang berakhir pada tanggal tersebut, 2024. [Online]. Tersedia: https://www.indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2024/q3/INAF_Q3_2024.pdf.

PT Indofarma Tbk, Laporan keuangan konsolidasian 31 Desember 2024 dan untuk tahun yang berakhir pada tanggal tersebut, 2025. [Online]. Tersedia: https://www.indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2024/q4/INAF_Q4_2024.pdf.

PT Indofarma Tbk, Laporan keuangan 31 Maret 2025 dan untuk periode tiga bulan yang berakhir pada tanggal tersebut, 2025. [Online]. Tersedia: https://www.indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2025/q1/INAF_Q1_2025.pdf.

PT Indofarma Tbk, Laporan keuangan 30 Juni 2025 dan untuk periode enam bulan yang berakhir pada tanggal tersebut, 2025. [Online]. Tersedia: https://indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2025/q2/INAF_Q2_2025.pdf.

PT Indofarma Tbk, Laporan keuangan 30 September 2025 dan untuk periode sembilan bulan yang berakhir pada tanggal tersebut, 2025. [Online]. Tersedia: https://indopremier.com/xdir/news/LAPORAN%20KEUANGAN/2025/q3/INAF_Q3_2025.pdf.

PT Indofarma Tbk, Laporan keuangan 31 Desember 2025 dan untuk tahun yang berakhir pada tanggal tersebut disertai laporan auditor independen, 2026. [Online]. Tersedia: https://cdn.financialreports.eu/financialreports/media/filings/69327/2025/RNS/69327_rns_2025-12-31_14bd373e-4a55-44e8-895c-d9e009150e3c.pdf.

I. Ghozali, Aplikasi analisis multivariate dengan program IBM SPSS 26, 10th ed. Badan Penerbit Universitas Diponegoro, 2021.

N. Shrestha, “Detecting multicollinearity in regression analysis,” American Journal of Applied Mathematics and Statistics, vol. 8, no. 2, pp. 39–42, 2020.

S. Das and U. Goel, “Determinants of excess and deficit cash holdings of firms: Evidence from emerging market,” Global Business Review, vol. 22, no. 5, pp. 1202–1215, 2021, doi: 10.1177/0972150918824950.

Downloads

Published

2026-10-19

How to Cite

Perputaran Kas Persediaan Likuiditas Leverage dan Profitabilitas PT Indofarma Tbk Studi Eksploratif Kuartalan 2023–2025. (2026). MANAJEMEN, 6(2), 124-137. https://doi.org/10.51903/586wqh12